Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Sagiv-Barfi, Idit
27  Ergebnisse:
Personensuche X
?
1

Targeted TLR9 Agonist Elicits Effective Antitumor Immunity ..:

Miller, Caitlyn L ; Sagiv-Barfi, Idit ; Neuhöfer, Patrick...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315437/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Systemic delivery of a targeted synthetic immunostimulant t..:

Miller, Caitlyn L ; Sagiv-Barfi, Idit ; Neuhöfer, Patrick...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134376/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

Intratumoral immunotherapy relies on B and T cell collabora..:

Sagiv-Barfi, Idit ; Czerwinski, Debra K ; Shree, Tanaya..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254330/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

Supporting the Next Generation of Scientists to Lead Cancer..:

Alspach, Elise ; Chow, Ryan D. ; Demehri, Shadmehr...
Cancer Immunology Research.  9 (2021)  11 - p. 1245-1251 , 2021
Link: https://doi.org/10.1158/..
 
?
5

An mRNA SARS-CoV-2 Vaccine Employing Charge-Altering Releas..:

Haabeth, Ole A. W. ; Lohmeyer, Julian J. K. ; Sallets, Adrienne...
ACS Central Science.  7 (2021)  7 - p. 1191-1204 , 2021
Link: https://doi.org/10.1021/..
 
?
6

An mRNA SARS-CoV-2 vaccine employing a novel delivery vehic..:

Haabeth, Ole A.W ; Lohmeyer, Julian J.K ; Sallets, Adrienne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057237/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
7

An mRNA SARS-CoV‑2 Vaccine Employing Charge-Altering Releas..:

Ole A. W. Haabeth (10994975) ; Julian J. K. Lohmeyer (10994978) ; Adrienne Sallets (1784629)...
https://figshare.com/articles/journal_contribution/An_mRNA_SARS-CoV_2_Vaccine_Employing_Charge-Altering_Releasable_Transporters_with_a_TLR_9_Agonist_Induces_Neutralizing_Antibodies_and_T_Cell_Memory/14810525.  , 2021
Link: https://doi.org/10.1021/..
 
?
8

Supporting the next generation of scientists to lead cancer..:

Alspach, Elise ; Chow, Ryan D ; Demehri, Shadmehr...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644410/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
9

768 Systemic delivery of a tumor-targeted TLR9 agonist conj..:

Idit Sagiv-Barfi ; Ronald Levy ; Caitlyn Miller Candidate...
https://doaj.org/toc/2051-1426.  , 2021
Link: https://doi.org/10.1136/..
 
?
10

An mRNA SARS-CoV‑2 Vaccine Employing Charge-Altering Releas..:

Ole A. W. Haabeth ; Julian J. K. Lohmeyer ; Adrienne Sallets...
https://doi.org/10.1021/acscentsci.1c00361.  , 2021
Link: https://doi.org/10.1021/..
 
?
11

Targeting CD137 enhances the efficacy of cetuximab:

Kohrt, Holbrook E ; Colevas, A. Dimitrios ; Houot, Roch...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546445/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
12

Eradication of spontaneous malignancy by local immunotherap:

Sagiv-Barfi, Idit ; Czerwinski, Debra K ; Levy, Shoshana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997264/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
13

S101, an Inhibitor of Proliferating T Cells, Rescues Mice F..:

Shir, Alexei ; Klein, Shoshana ; Sagiv-Barfi, Idit...
The Journal of Infectious Diseases.  217 (2017)  2 - p. 288-297 , 2017
Link: https://doi.org/10.1093/..
 
?
14

Therapeutic antitumor immunity by checkpoint blockade is en..:

Sagiv-Barfi, Idit ; Kohrt, Holbrook E. K. ; Czerwinski, Debra K....
Proceedings of the National Academy of Sciences.  112 (2015)  9 - p. , 2015
Link: https://doi.org/10.1073/..
 
?
15

Therapeutic antitumor immunity by checkpoint blockade is en..:

Sagiv-Barfi, Idit ; Kohrt, Holbrook E. K. ; Czerwinski, Debra K....
Proceedings of the National Academy of Sciences of the United States of America.  112 (2015)  9 - p. E966-E972 , 2015
Link: https://www.jstor.org/st..
 
1-15